Introduction
============

Articular cartilage damage is one of the most common diseases seen in the clinic, and has been a challenge in orthopedic medicine due to the poor self-healing ability of cartilage tissue ([@b1-mmr-17-06-8237]). Severe cartilage damage, initially caused by degeneration or trauma, may lead to osteoarthritis (OA) and subsequently cause joint pain and disability, creating a significant disease burden worldwide. Although various conservative interventions have been developed for the treatment of early OA, including oral nonsteroidal anti-inflammatory drugs and intra-articular hyaluronic acid injections, they only temporarily alleviate pain. For severe degenerative joint diseases, surgical arthroplasty is an effective treatment; however, it has significant postoperative complications. Due to the potential of chondrogenic differentiation and extensive proliferation of bone marrow mesenchymal stem cells (BMSCs), cartilage tissue engineering is currently considered to be one of the most promising techniques for the treatment of OA ([@b1-mmr-17-06-8237]). To induce chondrogenic differentiation of BMSCs, numerous growth factors are applied, which have previously been demonstrated to enhance chondrogenesis and promote formation of cartilage-like tissue ([@b2-mmr-17-06-8237]--[@b4-mmr-17-06-8237]). However, growth factors inevitably upregulate the expression levels of hypertrophic differentiation markers, including collagen x, matrix metalloproteinase 13 and alkaline phosphatase (ALP), and functionally contribute to calcification ([@b2-mmr-17-06-8237]--[@b5-mmr-17-06-8237]). Additional side effects of growth factor treatment limit their clinical use, including expense, rapid degradation and loss of activity ([@b6-mmr-17-06-8237]--[@b8-mmr-17-06-8237]). One strategy for addressing these issues is to investigate safe and low-cost drugs that may substitute or cooperate with growth factors to promote and maintain stable chondrogenic differentiation without hypertrophy ([@b6-mmr-17-06-8237],[@b7-mmr-17-06-8237]).

Herb Epimedium (HEP) is a traditional Chinese herb and is widely used to treat osteoporosis and OA in China, Japan and Korea ([@b8-mmr-17-06-8237]). Icariin (C~33~H~40~O~15~; molecular weight, 676.65) is the primary pharmacologically active compound of HEP. When chondrocytes were used as seed cells, icariin increased cartilage extracellular matrix (ECM) synthesis, suppressed ECM degradation, enhanced cartilage-specific gene expression including collagen II, aggrecan and SRY-type high mobility group box 9 (SOX9) *in vitro*, and additionally improved the repair of cartilage defects and prevented cartilage degradation *in vivo* ([@b6-mmr-17-06-8237],[@b7-mmr-17-06-8237],[@b9-mmr-17-06-8237],[@b10-mmr-17-06-8237]). The application of chondrocytes in cartilage tissue engineering is prevalent, yet it faces numerous challenges, including chondrocyte dedifferentiation, donor site morbidity and limited sources for harvesting cartilage tissue ([@b1-mmr-17-06-8237]). In an attempt to overcome these challenges, our recent study cultivated BMSCs with chondrogenic medium containing icariin in monolayer culture for 14 days, which is a traditional two-dimensional (2D) cell culture, and demonstrated that icariin promoted directed chondrogenesis of BMSCs and had no effect on hypertrophic differentiation ([@b11-mmr-17-06-8237]). However, chondrogenic potential of stem cells or chondrocytes cultured in a three-dimensional (3D) microenvironment is different from 2D culture ([@b12-mmr-17-06-8237],[@b13-mmr-17-06-8237]). Thus, icariin may be a potential accelerator for cartilage tissue engineering; however, its effects on BMSCs in a 3D microenvironment require further investigation to elucidate its clinical application.

To culture BMSCs in a 3D microenvironment, the scaffold is a critical component and should mimic the structural and functional properties of the native ECM to accommodate cells, and additionally facilitate cell migration, proliferation and differentiation. Self-assembling peptides are a relatively novel class of molecules that have the ability to form stable nanofiber hydrogels upon exposure to physiological pH and ionic strength. The self-assembling peptide nanofiber hydrogel scaffold exhibits excellent biocompatibility, supports the chondrocyte phenotype ([@b14-mmr-17-06-8237]), promotes BMSCs proliferation and chondrogenic differentiation *in vitro* ([@b15-mmr-17-06-8237]--[@b18-mmr-17-06-8237]), and stimulates cartilage regeneration or improves clinical symptoms *in vivo* ([@b19-mmr-17-06-8237],[@b20-mmr-17-06-8237]). Therefore, a self-assembling peptide hydrogel scaffold was considered as an ideal scaffold for 3D cell culture and cartilage tissue engineering ([@b21-mmr-17-06-8237]).

The present study extended our previous investigations to observe the effect of icariin on chondrogenic differentiation of BMSCs in a self-assembling peptide nanofiber hydrogel scaffold. To the best of our knowledge, this is the first report of its kind. These findings demonstrated that icariin promotes BMSCs chondrogenesis; however, has no significant effect on hypertrophic differentiation in a 3D microenvironment.

Materials and methods
=====================

### Cell culture of rat BMSCs

OriCell™ Sprague-Dawley rat BMSCs (catalog no. RASMX-01001) were purchased from Cyagen Biosciences Inc. (Guangzhou, China). Cell viability, sterility, purity, proliferation and differentiation ability were tested by the company, which revealed that cells were highly positive for the specific mesenchymal markers CD29 (83.99%), CD44 (99.69%) and CD90 (95.05%), and negative for the hematopoietic cell-surface markers CD34 (0.62%), CD45 (0.28%), and CD11b (4.25%). To verify pluripotency, BMSCs were able to differentiate into osteoblasts, chondrocytes and adipocytes. Cells were thawed at 37°C in a water bath and resuspended in low glucose Dulbecco\'s modified Eagle\'s medium (LG-DMEM) supplemented with 10% fetal bovine serum, 10 U/ml penicillin G and 10 mg/ml streptomycin, all purchased from Hyclone (GE Healthcare Life Sciences, Logan, UT, USA). The cell suspension was subsequently plated into T25 flasks and incubated in a 5% carbon dioxide humidified incubator at 37°C. Upon achieving 80--90% confluence, cells were treated with 0.25% trypsin/1 mM ethylenediaminetetraacetic acid (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 3--5 min. In order to harvest an adequate number of cells, cells at passage 5 to 7 were used in this study.

### Hydrogel encapsulation and 3D culture

A BeaverNano™ 3D hydrogel scaffold (catalog no. P0030105; Cyagen Biosciences Inc.), which was a self-assembling peptide nanofiber scaffold with pore sizes between 50 and 200 nm, was selected because it had 3D nanofiber structures similar to natural cartilage ECM. The molecular mode (Ac-RADARADARADARADA-CONH~2~), microstructure (visualized by scanning electron microscopy and atomic force microscopy) and preparation of the hydrogel scaffold are detailed by the manufacturer (Beaver Nano-Technologies Co., Ltd., Suzhou, China), and a 0.25% concentration was applied in the present study. Briefly, 1.0% (w/v) hydrogel stock solution was mixed with an equal volume of 20.0% (w/v) sucrose solution. Following trypsinization, BMSCs were centrifuged at 400 × *g* for 5 min at 4°C, resuspended in 10.0% (w/v) sucrose solution, and quickly encapsulated in an equal volume of 0.50% (w/v) concentration peptide scaffolds to make a final concentration of 1.0×10^7^ cells/ml. The cell density was selected to match a previous study ([@b15-mmr-17-06-8237]). The cell/hydrogel mixture (300 µl) was immediately dropped onto the bottom of each cell culture well (200 mm^2^/hole; EMD Millipore, Billerica, MA, USA) and allowed to form a layer \~1.50-mm thick. LG-DMEM medium (500 µl) was added to the top of the scaffold to induce self-assembly. The cell/hydrogel scaffolds were incubated in a humidified atmosphere with 5% CO~2~ at 37°C.

### Chondrogenic differentiation

Following self-assembly, the cell/hydrogel scaffolds were cultured in control medium without chondrogenic supplements, or chondrogenic medium (catalog no. GUXMX-90041, Cyagen Biosciences Inc.) containing 10 ng/ml transforming growth factor (TGF)-β3 in the presence or absence of 1×10^−6^ M icariin (labeled control, TGF-β3 + icariin or TGF-β3 groups, respectively). Icariin (purity: 99%) was purchased from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). OriCell^™^ MSC chondrogenic differentiation medium contained 0.1 µM dexamethasone, 50 µg/ml ascorbate, 1% insulin-transferrin-selenium cell culture supplement, 100 µg/ml sodium pyruvate, 40 µg/ml proline and 10 ng/ml TGF-β3. In the TGF-β3 + icariin group, icariin was dissolved in dimethyl sulfoxide and subsequently added to chondrogenic differentiation medium at concentrations of 1×10^−6^ M, according to our preliminary experiments ([@b11-mmr-17-06-8237]). The culture medium was replaced every other day, and the morphology of BMSCs was observed under a CKX41 inverted microscope (Olympus Corporation, Tokyo, Japan). At each time point (days 7, 14 and 21), the scaffold, cell lysis and culture medium were harvested for further experiments. All experiments were performed at least three times.

### Histology and immunohistochemistry

Cell/hydrogel scaffolds were fixed in 4% paraformaldehyde and permeabilized in PBS containing 0.1% Triton X-100 at room temperature for 30 min. Following blocking with 5% bovine serum albumin (GE Healthcare Life Sciences) for 2 h, samples were treated with the following primary antibodies: Rabbit anti-collagen II (catalog no. GTX20300; 1:100; GeneTex, Inc., Irvine, CA, USA), rabbit anti-SOX9 (catalog no. ab71762; 1:200; Abcam, Cambridge, UK) or mouse anti-collagen × (catalog no. ab49945; 1:200; Abcam) at 4°C overnight, washed three times with PBS, and subsequently incubated with cy3-labeled goat anti-rabbit fluorescent secondary antibody (catalog no. A0516; 1:1,000; Beyotime Institute of Biotechnology, Shanghai, China) or cy3-labeled goat anti-mouse fluorescent secondary antibody (catalog no. A0521; 1:1,000; Beyotime Institute of Biotechnology) for 2 h at room temperature in the dark. Cell nuclei were stained with 4, 6-diamidion-2-phenylindole (catalog no. C1006; 1:1,000; Beyotime Institute of Biotechnology) for 3 min. Subsequently, stained samples were imaged under a Leica DM4000 B fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany). Additional samples were washed three times with PBS and stained for sulfated proteoglycans with toluidine blue dye solution (0.50%; Abcam) for 5 min, and subsequently observed under an inverted microscope (Olympus Corporation, Tokyo, Japan).

### Cell abstraction from hydrogel scaffold and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

At days 7, 14 and 21, BMSCs from hydrogel scaffolds were harvested by mechanical disruption with a micropipette until single cells were obtained. Cells were subsequently centrifuged at 400 × *g* for 5 min at 4°C, and the supernatant was removed, rinsed with LG-DMEM and centrifuged again under the same conditions. Total RNA was extracted from culture cells using an RNAiso Plus reagent (Takara Biotechnology, Co., Ltd., Dalian, China) following the manufacturer\'s protocol, and absorbance was measured at a wavelength of 260 nm using a spectrophotometer (DU-70; Beckman, Fullerton, CA, USA) to determine the diluted RNA concentration. Each sample (1 µg) was reverse transcribed using a PrimeScript^™^ RT reagent kit with gDNA Eraser (Takara Biotechnology Co., Ltd.). qPCR reactions were performed using an Applied Biosystems 7500 Fast Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) and SYBR^®^ Premix Ex Taq™ II reagent (Takara Biotechnology Co., Ltd.). Equal quantities of cDNA and specific primers were added to the mix, and the following cycle parameters of PCR was used: Initial denaturation at 94°C for 30 sec, followed by 40 cycles of denaturation at 94°C for 5 sec, annealing at 60°C for 15 sec and extension at 72°C for 10 sec. The sequences of forward and reverse primers used for collagen type II α 1 (col2α1; collagen II gene), SOX9, collagen type I α 1 (col1α1; collagen I gene) and collagen type X α 1 (col10α1; collagen × gene) are listed in [Table I](#tI-mmr-17-06-8237){ref-type="table"}. As described previously ([@b11-mmr-17-06-8237]), mRNA expression levels were analyzed by the 2^−ΔΔCq^ method using the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control.

### ALP activity

ALP is one of the most common indicators of hypertrophic differentiation, and was measured in culture supernatants as described previously ([@b11-mmr-17-06-8237]). At 7, 14 and 21 days, the medium was replaced with phenol red-free DMEM supplemented with 10% fetal bovine serum, 10 U/ml penicillin G and 10 mg/ml streptomycin (GE Healthcare Life Sciences). Supernatants was collected after 1 day and centrifuged at 1,400 × *g* for 10 min at 4°C to remove particles. ALP activity was immediately assayed using a commercial ALP kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer\'s protocol.

### Statistical analysis

All data are expressed as mean ± standard deviation. The differences between multiple-group comparisons were analyzed by one-way analysis of variance followed by Tukey\'s post hoc test. P\<0.05 was considered to indicate a statistically significant difference. Statistical tests were performed using SPSS software version 16.0 (SPSS, Inc., Chicago, IL, USA).

Results
=======

### Effect of icariin on the biosynthesis of ECM

To evaluate the effect of icariin on BMSC chondrogenesis in self-assembling peptide nanofiber hydrogel scaffolds, immunofluorescence was performed after 7, 14 and 21 days of culture. Collagen II is a primary component of cartilage ECM produced by chondrocytes. At each time point, TGF-β3 and TGF-β3 + icariin groups were positive for collagen II staining; however, the control medium was negative. Analysis of multiple sections of hydrogels revealed that icariin treatment led to more intense and uniformly distributed staining throughout the hydrogel scaffold at day 7 to 21 compared with the TGF-β3 group ([Fig. 1A](#f1-mmr-17-06-8237){ref-type="fig"}). Notably, staining was concentrated to the cell clusters (red arrows), while little staining was detected in single cells (white arrows).

SOX9 is considered to be an early chondrogenic marker and serves a pivotal role in MSC chondrogenesis. The present study stained hydrogel scaffolds with a SOX9-specific antibody after 7 days in culture, and the results demonstrated that cells cultured with TGF-β3 + icariin medium exhibited markedly increased positive staining compared with cells in TGF-β3 only medium, and no staining was present in control medium ([Fig. 1B](#f1-mmr-17-06-8237){ref-type="fig"}).

Toluidine blue staining of day 21 hydrogels ([Fig. 1C](#f1-mmr-17-06-8237){ref-type="fig"}) was consistent with the collagen II staining ([Fig. 1A](#f1-mmr-17-06-8237){ref-type="fig"}), demonstrating that the cells were enclosed in a metachromatic matrix. The TGF-β3 + icariin group had more proteoglycan deposition compared with the TGF-β3 group, which was reflected by more intense staining. In addition, chondrocyte-like rounded cells were observed in the TGF-β3 + icariin and TGF-β3 groups.

### Effect of icariin on expression levels of chondrogenesis-specific genes

To further assess chondrogenesis of BMSCs in self-assembling peptide nanofiber hydrogel scaffolds at a genetic level, mRNA expression levels of the chondrogenesis-specific genes col2α1 and SOX9 were determined using RT-qPCR. Compared with the control group, the expression levels of col2α1 and SOX9 mRNA continued to significantly increase from days 7 to 21 in the TGF-β3 and TGF-β3 + icariin groups. Compared with the TGF-β3 group, col2α1 gene expression in the TGF-β3 + icariin group was increased by 1.80-fold (P\<0.01), 1.60-fold (P\<0.05) and 1.20-fold (P\>0.05) at days 7, 14 and 21, respectively ([Fig. 2A](#f2-mmr-17-06-8237){ref-type="fig"}). Consistent with the expression levels of col2α1 mRNA, icariin treatment led to a 1.65-, 1.56- and 1.31-fold increase in SOX9 expression levels at days 7, 14 and 21 in comparison with the TGF-β3 group ([Fig. 2B](#f2-mmr-17-06-8237){ref-type="fig"}).

### Effect of icariin on cell morphology during chondrogenesis

Due to the transparency of the self-assembled peptide nanofiber scaffold, the morphology of BMSCs encapsulated in the scaffold during chondrogenesis was easily observed. As presented in [Fig. 3](#f3-mmr-17-06-8237){ref-type="fig"}, spherical, isolated and uniformly seeded cells were observed prior to chondrogenic induction at day 0. In the TGF-β3 and TGF-β3 + icariin groups, BMSCs became elongated with long processes and cell-cell contacts with a clustered morphology at day 3, and the shape of BMSCs further altered from clusters to fibroblasts, and exhibited a spread morphology at day 7. In the control medium, cells maintained the same spherical, isolated morphology as at day 0. Despite these early differences, cells cultured in TGF-β3 + icariin medium had a more chondrocyte-like rounded morphology compared with the TGF-β3 only group at day 21, whereas a fibroblastic morphology was visible in the TGF-β3 group.

### Effect of icariin on hypertrophic differentiation

The present study evaluated the hypertrophic differentiation markers, collagen × (col10α1 gene), ALP and collagen I (col1α1 gene), using immunofluorescence and RT-qPCR analysis. After 21 days of culture, compared with the control group ([Fig. 4A](#f4-mmr-17-06-8237){ref-type="fig"}), which had no collagen × staining, the TGF-β3 group revealed strong staining ([Fig. 4B](#f4-mmr-17-06-8237){ref-type="fig"}). However, treatment with TGF-β3 + icariin ([Fig. 4C](#f4-mmr-17-06-8237){ref-type="fig"}) did not lead to more intense staining compared with the TGF-β3 group, which was consistent with the results of col10α1 mRNA expression levels ([Fig. 4D](#f4-mmr-17-06-8237){ref-type="fig"}). ALP activity was additionally quantified in supernatants of cell culture. Similar to the results observed for collagen x, the group treated with TGF-β3 at day 7 exhibited significantly increased ALP activity compared with the control group, whereas a reduction in ALP activity was detected in the TGF-β3 + icariin group compared with the TGF-β3 group ([Fig. 4E](#f4-mmr-17-06-8237){ref-type="fig"}). Collagen I was considered as a hypertrophic differentiation and dedifferentiation marker of chondrocytes ([@b22-mmr-17-06-8237]). qPCR analysis revealed that the expression levels of col1α*1* in the TGF-β3 group were increased significantly at days 14 and 21 compared with the untreated controls; however, the mRNA levels were decreased in the TGF-β3 + icariin group compared with the TGF-β3 group, although this difference was not significant ([Fig. 4F](#f4-mmr-17-06-8237){ref-type="fig"}).

Discussion
==========

Based on our previous findings that icariin promoted chondrogenic differentiation in traditional monolayer 2D culture ([@b11-mmr-17-06-8237]), the present study hypothesized that icariin may improve cartilage ECM production and reduce hypertrophic differentiation in 3D scaffolds seeded with BMSCs. To maintain a chondrocyte phenotype in monolayer traditional cultures and promote chondrogenesis, various scaffolds chemically conjugated with icariin have previously been used for cartilage tissue engineering, including hyaluronic acid-icariin/collagen hydrogels ([@b23-mmr-17-06-8237]), hyaluronic acid-icariin conjugate hydrogels ([@b24-mmr-17-06-8237]) and gelatin/hyaluronic acid-icariin composite microspheres ([@b25-mmr-17-06-8237]). Among these biomaterials, self-assembling peptide nanofiber hydrogels are a relatively new scaffold and have emerged as a promising cartilage tissue engineering scaffold for simultaneous cell growth and drug delivery ([@b21-mmr-17-06-8237]). As it is easily loaded with cells, growth factors and drugs, the present study examined the hypothesis by adding icariin and TGF-β3 into self-assembling peptide nanofiber hydrogel scaffolds to induce chondrogenic differentiation, and subsequently comparing ECM biosynthesis, gene expression levels and cell morphology. The results of the present study demonstrated that icariin promotes production of ECM components including collagen II protein, and additionally enhances chondrogenesis-specific genes mRNA expression levels, including col2α1 and the early chondrogenic marker, SOX9.

Consistent with these results, Li *et al* ([@b7-mmr-17-06-8237]) added icariin into chondrocyte-hydrogel scaffolds and reported that icariin markedly upregulated cartilage-specific gene expression levels of seeded chondrocytes, and accelerated the formation of cartilage-like tissue. They additionally investigated the effect of icariin on the restoration of osteochondral defects, and observed that icariin improved the restoration efficiency and enhanced the integration of new-formed cartilage with subchondral bone. Similarly, when icariin was chemically conjugated to hyaluronic acid/collagen hydrogel scaffolds, the fixed icariin was gradually released, effectively maintaining chondrocyte morphology, promoting cartilage matrix synthesis and forming improved new cartilage tissue ([@b23-mmr-17-06-8237]). Others have investigated the effects of icariin on chondrgogenesis for either chondrocytes or BMSCs in 2D culture, and have demonstrated that the promotion effects of icariin are consistent with those in 3D culture ([@b6-mmr-17-06-8237],[@b11-mmr-17-06-8237]). Therefore, these results suggested that icariin promotes the growth of neocartilage and may be a substitute for the use of certain growth factors in cartilage tissue engineering.

Self-assembling peptide nanofiber hydrogel scaffolds are transparent, allowing cells to be observed directly and clearly. In the present study, BMSC morphology began to alter clearly at day 3, and cell-cell contacts with a clustered morphology were observed in the TGF-β3 and TGF-β3 + icariin groups. At day 7, the shape of BMSCs further altered from clusters to fibroblasts, exhibiting a spread morphology, and subsequently altered to a chondrocyte-like rounded morphology at day 21, whereas cells maintained the same spherical, isolated morphology in the control medium. The morphological events during chondrogenesis were consistent with numerous previous reports that BMSCs encapsulate in self-assembling peptides ([@b15-mmr-17-06-8237]), pellet culture systems ([@b26-mmr-17-06-8237]) and collagen gel scaffolds ([@b27-mmr-17-06-8237]). Particularly, the aggregation phase was commonly observed in monolayer 2D cultures and scaffold 3D cultures ([@b11-mmr-17-06-8237],[@b15-mmr-17-06-8237],[@b27-mmr-17-06-8237]). Ichinose *et al* ([@b27-mmr-17-06-8237]) demonstrated that aggregation of chondroprogenitors was the first step for cartilage formation. Kopesky *et al* ([@b15-mmr-17-06-8237]) reported that cell-cell contact stimulates cell mitotic activity, and subsequently undergo overt chondrogenesis. The present study revealed that staining was concentrated to cell clusters, whereas little staining was detected in single cells. Thus, increased cell-cell contact in the TGF-β3 + icariin group compared with the TGF-β3 group may be influential in promoting the chondrogenic effect of icariin.

The present study additionally examined hypertrophic differentiation markers and demonstrated that TGF-β3 medium increased the mRNA expression levels of col10α1, and col1α1, and increased the activity of ALP. Previous reports have demonstrated that growth factors enhance chondrogenesis, promote formation of cartilage-like tissue, and inevitably upregulate the expression levels of hypertrophic differentiation markers ([@b2-mmr-17-06-8237]--[@b5-mmr-17-06-8237]). The TGF-β3 + icariin group exhibited reduced expression levels of these hypertrophic differentiation markers, suggesting that icariin had no promotion effect on hypertrophy. Consistent with these results, Zhang *et al* ([@b6-mmr-17-06-8237]) and Li *et al* ([@b7-mmr-17-06-8237]) reported that icariin downregulates col1α1 mRNA expression levels in chondrocytes.

In conclusion, the present study investigated the effects of icariin treatment on BMSC chondrogenic specific gene expression and ECM synthesis, and characterized cell morphology alterations in self-assembling peptide nanofiber hydrogel scaffolds. It was demonstrated that icariin treatment enhanced cartilage ECM synthesis and cartilage-specific genes expression levels in a 3D microenvironment. However, icariin treatment did not promote hypertrophic differentiation, suggesting that it may inhibit growth factor activity, thus preventing further hypertrophic differentiation. Therefore, these results indicated that icariin may be a potential compound useful for cartilage tissue engineering.

The present study was supported by the National Natural Science Foundation of China (grant nos. 81273508 and 81350017).

![Effect of icariin on the biosynthesis of the extracellular matrix, as detected by immunofluorescence and toluidine blue staining. (A) Cells were stained for collagen II (red) and nuclei were stained with DAPI (blue) after 7, 14 and 21 days in culture. The red arrows indicate collagen II staining in cell clusters, and white arrows indicate staining in single cells. (magnification, ×100). (B) Cells were stained for SOX9 (red) after 7 days in culture (magnification, ×100). (C) Cells were stained with toluidine blue dye solution after 21 days in culture (magnification, ×40). SOX9, SRY-type high mobility group box 9; TGF-β3, transforming growth factor-β3.](MMR-17-06-8237-g00){#f1-mmr-17-06-8237}

![Effect of icariin on gene expression levels of cartilage-specific markers were analyzed by reverse transcription-quantitative polymerase chain reaction after 7, 14 and 21 days in culture. (A) Col2α1 and (B) SOX9 gene mRNA expression levels. GAPDH served as an internal control. \*P\<0.05 and \*\*P\<0.01 vs. control group; ^\#^P\<0.05 and ^\#\#^P\<0.01 vs. TGF-β3 group. Col2α1, collagen type II α 1; SOX9, SRY-type high mobility group box 9; TGF-β3, transforming growth factor-β3.](MMR-17-06-8237-g01){#f2-mmr-17-06-8237}

![Effect of icariin on cell morphology during chondrogenic differentiation at days 0, 3, 7 and 21. Black arrows indicate cell-cell contacts with a clustered morphology, white arrows indicate fibroblastic spread morphology and double black arrows indicate chondrocyte-like rounded morphology. Magnification, ×100. TGF-β3, transforming growth factor-β3.](MMR-17-06-8237-g02){#f3-mmr-17-06-8237}

![Effect of icariin on hypertrophic differentiation markers. Collagen × was detected by immunofluorescence in (A) control, (B) TGF-β3-treated and (C) TGF-β3 + icariin-treated cells (magnification, ×100). (D) Col10α1 gene expression levels were analyzed by RT-qPCR. (E) Soluble ALP activity was quantified in culture supernatants. (F) Col1α*1* gene expression levels were analyzed by RT-qPCR. \*\*P\<0.01 vs. control; \*P\<0.05 vs. control; ^\#^P\<0.05 vs. TGF-β3. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; TGF-β3, transforming growth factor-β3; Col10α1, collagen type X α I; ALP, alkaline phosphatase; Col1α1, collagen type I α 1.](MMR-17-06-8237-g03){#f4-mmr-17-06-8237}

###### 

Primer sequences.

  Gene                                                      Forward (5′-3′)             Reverse (5′-3′)
  --------------------------------------------------------- --------------------------- -------------------------
  Col2α1^[a](#tfn1-mmr-17-06-8237){ref-type="table-fn"}^    CGCCACGGTCCTACAATGTC        GTCACCTCTGGGTCCTTGTTCAC
  SOX9^[a](#tfn1-mmr-17-06-8237){ref-type="table-fn"}^      GCAGAGACTGAAGACCCTACACAGA   GAGGCAACTTCACGCTGCAA
  Col1α1^[b](#tfn2-mmr-17-06-8237){ref-type="table-fn"}^    GCCTCCCAGAACATCACCTA        GCAGGGACTTCTTGAGGTTG
  Col10α1^[b](#tfn2-mmr-17-06-8237){ref-type="table-fn"}^   GCCAGGACCTCCAGGACTATCA      CCCAATGTCTCCTTTCGGTCCA
  GAPDH^[c](#tfn3-mmr-17-06-8237){ref-type="table-fn"}^     TATGACTCTACCCACGGCAA        

Chrondrogenic markers

hypertophic markers

internal control. Col2α1, collagen type II α 1; SOX9, SRY-type high mobility group box 9; Col1α1, collagen type I α 1; Col10α1, collagen type X α 1.
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